Equity markets were subdued this week as positive incoming vaccine news was offset against ever-growing economic restrictions in the U.S. and Europe, aimed at curbing the recent spike in virus cases. On the vaccine front, the world received more positive news, following on from Pfizer and BioNTech’s announcement last week, with Moderna stating that its Covid-19 vaccine candidate is 94.5 percent effective. Both vaccines are based on introducing genetic material, mRNA, into the human body in order to produce spike proteins which prevents the coronavirus from entering human cells.
Meanwhile, The University of Oxford confirmed that the Covid-19 vaccine it is developing with AstraZeneca Plc, produced strong immune responses in older adults, with pivotal findings from the final phase of trials expected in the coming weeks. In less positive news, the U.S. crossed a grim milestone with fatalities attributed to Covid-19 crossing 250,000.
U.S. economic data releases during the week were mostly soft. Weekly jobless claims rose for the first time in over a month, from 711,000 to 742,000. Retail sales excluding autos in October also missed expectations and grew at the slowest pace (0.2%) since April, whilst industrial production rose a bit more than expected in October, but regional manufacturing gauges indicated slowing expansion.
Whilst President Trump continues to refuse to concede the recent election, his efforts were dealt another blow with President-elect Biden’s victory in Georgia confirmed by a recount. The Democrats beat the Republicans in Georgia by 12,284 votes, according to the audit required by state law.
In Europe, Hungary and Poland blocked the EU planned EUR 1.8 trillion fiscal package. Both countries opposed a mechanism that would allow the EU to block disbursements to countries violating its rule of law principles. German Chancellor Angela Merkel said she would hold talks with the leaders of the two countries while defending the existing proposal.
Brexit trade deal negotiations are down to the wire and expected to continue through the weekend and possibly into next week. If both sides don’t sign a trade deal, Britain will default to trading with the EU on WTO terms. France, the Netherlands, and Belgium urged the EU to start implementing contingency measures in case there is no deal before the Brexit transition ends on December 31.
Japan’s economy grew by 21.4% (annualised) in the third quarter, ahead of consensus estimates for a 18.9% increase. Prime Minister Suga and the International Olympic Committee also agreed that the Tokyo Olympics should be held despite the latest surge in the pandemic. The Olympic games are scheduled to be held from July 23 to August 8, 2021.
U.S. markets ended the week mostly negative, with the Dow Jones Industrial Average (-0.73%) and S&P 500 (-0.77%) both in the red compared to a mildly positive Nasdaq (+0.22%). This compares to European and Asian markets which both managed to finish the week in positive territory. In Europe, FTSE 100 Index (+0.56%) and Euro Stoxx 50 (+1.04%) were stronger along with the Nikkei (+0.56%) and China’s Shanghai Composite Index (+2.04%).
Market Moves of the Week
Global ratings agencies Fitch and Moody’s both downgraded South Africa’s sovereign credit rating further into junk on Friday evening, citing a combination of SA’s weakening fiscal position, rising government debt and economic weakness triggered by the Covid-19 pandemic as the reasons for the downgrades. The third rating agency, S&P, chose to keep SA’s sovereign credit rating assessment unchanged. Expectations were for all three ratings agencies to leave assessments unchanged.
As it now stands, Fitch and S&P rate SA’s long-term foreign-currency debt at three notches below investment grade, whilst Moody’s rates the country’s long-term foreign-currency debt at two notches below investment grade.
On Thursday, the South African Reserve Bank decided to leave the Repo rate unchanged at 3.50%. Two members of the MPC voted for a cut of 25bps, while three members wanted rates to remain on-hold.
Overall, the Reserve Bank appears to be very comfortable with the outlook for inflation. The Bank’s headline consumer price inflation forecast averages 3.2% in 2020 and is slightly lower than previously forecast for 2021 at 3.9% and remains at 4.4% in 2022. The growth rate for 2020 is now expected to be -8.0%, compared to a contraction of 8.2% at the time of the September MPC meeting. GDP is expected to grow by 3.5% in 2021 and by 2.4% in 2022.
The JSE All Share Index ended the week down -0.99%, with all three of the major sectors including industrials (-1.48%), financials (-1.99%) and resources (-0.12%) weaker. By Friday close, the rand traded at R15.41 to the U.S. Dollar and R20.49 to the Pound Sterling.
Chart of the Week
As the race to deliver the first coronavirus vaccine heats up, many investors are considering buying shares of the companies currently ahead of the pack, hoping for a healthy return in case of a breakthrough. Pfizer and BioNTech were the latest to announce a major milestone on Wednesday, as their vaccine candidate turned out to be 95% effective against Covid-19 in a completed Phase 3 study. Earlier this week, Moderna had announced a similar efficacy rate for its vaccine candidate based on preliminary Phase 3 trials results, while Oxford University and AstraZeneca announced that their candidate produces a strong immune response in elderly and older adults.
For assistance or more information, contact your Carrick Wealth Specialist directly or alternatively contact us at
The information contained herein as well as the individual companies and/or securities mentioned should not be construed as investment advice, a recommendation to buy or sell, or an indication of trading intent on behalf of Carrick or any financial product. This communication is intended to be used for information purposes only by its designated recipients and is not an offer, recommendation or solicitation to transact. While it is based on information freely available to the public and from sources believed to be credible and reliable, Carrick Wealth makes no representation that it is accurate or complete or that any returns indicated will be achieved. Carrick Wealth is a registered South African financial services provider specialising in South African and international financial planning and integrated wealth management solutions. The Carrick corporate group is also licensed in Zimbabwe and Malawi, and holds three global licences in Mauritius.